RADX
Radiopharm Theranostics Limited
NASDAQ · Healthcare · Biotechnology · AU
$2.08
−3.48%Next report
Analyst consensus
- Next report date
- Feb 26, 2027
- EPS estimate
- -$1.05
- Revenue estimate
- $699.3K
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- -$1.67
- EPS estimate
- -$1.67
- Revenue actual
- $845.2K
- Revenue estimate
- $845.2K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 26, 2027